Inventor
HUELSMEYER MARTIN
DE13 patents
⚠️ This page may combine multiple inventors who share the name “HUELSMEYER MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PIERIS PHARMACEUTICALS GMBH
7 patentsUS10273275B2Apr 30, 2019
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof
PIERIS PHARMACEUTICALS GMBH10 citations82
US10046027B2Aug 14, 2018
Muteins of tear lipocalin and methods for obtaining the same
PIERIS PHARMACEUTICALS GMBH8 citations82
US10618941B2Apr 14, 2020
Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target
PIERIS PHARMACEUTICALS GMBH6 citations81
US10526384B2Jan 7, 2020
Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof
PIERIS PHARMACEUTICALS GMBH5 citations72
US11827681B2Nov 28, 2023
Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target
PIERIS PHARMACEUTICALS GMBH0 citations59
US9751920B2Sep 5, 2017
Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
PIERIS PHARMACEUTICALS GMBH0 citations51
US10787491B2Sep 29, 2020
Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)
PIERIS PHARMACEUTICALS GMBH0 citations50